SUBSCRIBE
SUBSCRIBE
Pharm Country

Cellectis Reports Results From Shareholders’ General Meeting Held On May 17, 2016

May 20, 2016 | 
1 min read
NEW YORK--(BUSINESS WIRE)--Regulatory News:

Cellectis S.A. Shareholders’ General Meeting (Paris:ALCLS) (NASDAQ:CLLS) (Alternext: ALCLS - Nasdaq: CLLS) was held on Tuesday, May 17, 2016 in Paris, at its head office.
Events
MORE ON THIS TOPIC
IN PARTNERSHIP WITH PATSNAP
Webinar: Beyond Theory: Real-World AI Wins in Life Science R&D, Faster & Smarter
June 25, 2025
 · 
1 min read
 · 
BioSpace Insights
Pictured: (From L) Joe Ross, Camille Bedrosian, Emil Kakkis and Heather McKenzie
Rare diseases
FDA Conditional Pathway Not Necessary, Rare Disease Experts Say, While Applauding Intent
June 24, 2025
 · 
3 min read
 · 
Heather McKenzie
From left to right: Jeff Quillen, Foley Hoag; Jim Cirenza, DNB Bank; Andrew Meadow, Health Innovation Capital; Greg Benning, Back Bay Life Science Advisors; Jonathan Gertler, Back Bay Life Science Advisors
Collaboration
Partner-Seeking Biotechs Find Plenty of Hands To Shake as BIO2025 Kicks Off
June 16, 2025
 · 
2 min read
 · 
Jef Akst
Chicago, Illinois, USA on Lake Michigan at dawn.
Cancer
Practice-Changing Data, Innovative Modalities and China in Focus at #ASCO25
May 27, 2025
 · 
7 min read
 · 
Tristan Manalac